WHO Consults On New Measures To Improve Medicines Access
Executive Summary
A draft roadmap lists initiatives to be undertaken between 2019 and 2023 to help improve access to medicines and vaccines.
You may also be interested in...
Transparency, IP Issues Dominate Discussion On WHO's Roadmap To Improve Drug Access
Advocacy groups want the WHO's proposed roadmap on improving access to medicines to include stronger language on transparency of R&D costs, prices and revenues. The pharmaceutical industry, however, believes any forward-looking solution should rest upon strong IP protection.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.